Mari Anne Snow is the CEO and co-founder of Eascra Biotech, a Massachusetts-based life sciences company pioneering the development of space-made therapeutics using its proprietary Janus Base Nanoparticle (JBNp) platform. Under her leadership, Eascra has become a multi-award recipient of NASA and NSF programs advancing in-space manufacturing for next-generation nanomedicines. A longtime advocate for patient-centered innovation and responsible technology development, Mari Anne brings a pragmatic business lens to the evolving low-Earth orbit (LEO) economy. Her work bridges biotechnology, space infrastructure, and healthcare delivery—building the foundations for safe, effective, and commercially viable space-enabled medicines designed to improve global health outcomes.